Faster Entry Sought for Generics

Faster Entry Sought for Generics Despite efforts to speed up approval of generic drugs, Americans still spend billions extra for prescriptions because of delays engineered by brand-name pharmaceutical companies. Pending legislation could help.


Biotech IPO Pipeline Fills Up

Biotech IPO Pipeline Fills Up With the biotech sector surging this year, private companies in the field see a chance to pull in some cash. But follow some key steps before buying.


Biotechblog